Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration

Handbook of Environmental Chemistry, Volume 5: Water Pollution

Volumn 38, Issue 4, 2006, Pages 342-346

  Fernandez Varon E ^a   Ayala, I ^a   Marin P ^a   Carrion A ^a   Martos, N ^a   Escudero, E ^a   Carceles C M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Bioavailability; Danofloxacin; Horse; Pharmacokinetics; Tissue irritation

Indexed keywords

BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS;

ANTIINFECTIVE AGENT; CREATINE KINASE; DANOFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGESTIVE TRACT INTUBATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; HORSE DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE KINASE; CROSS-OVER STUDIES; FLUORESCENCE; FLUOROQUINOLONES; HORSE DISEASES; HORSES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INTUBATION, GASTROINTESTINAL;

EID: 33947324691     PISSN: 14336863     EISSN: 04251644     Source Type: Book Series    
DOI: 10.2746/042516406777749245     Document Type: Article

References (36)

1. Aliabadi, F. and Lees, P. (2003) Pharmacokinetic-pharmacodymics integration of danofloxacin in the calf. Res. vet. Sci. 74, 247-259.
2. Aliabadi F. and Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. Am. J. vet. Res. 62, 1979-1989.
3. Aliabadi, F., Landoni, M.F. and Lees, P. (2003a) Pharmacokinetics (PK), Pharmacodymics (PD), and PK-PD integration of danofloxacin in Sheep biological fluids. Antimicrob. Agents Chemother. 47, 626-635.
4. Aliabadi, F., Badrelin, H., Landoni, M.F. and Lees, P. (2003b) Pharmacokinetics and PK-PD modelling of danofloxacin in in camel serum and tissue cage fluids. Vet. J. 165, 104-118.
5. Atef, M., El-Gendi, A.Y., Aziza., Amer, M.M. and Abd El-Aty, A.M. (2001) Some pharmacokinetic data for danofloxacin in healthy gotas. Vet. Res. Commun. 25, 367-377.
6. Bertone, A.L., Tremaine, W.H., Macoris, D.G., Simmons, E.J., Ewert, K.M., Herr, L.G. and Weisbrode, S.E. (2000) Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses. J. Am. vet. med. Ass. 217, 1514-1521.
7. Bostian, A., Vibrette, S., Bermingham, E. and Papich, M.G. (1998) Quinolone-induced arthropathy in neonatal foals. In: Proceedings of the 16th Annual Veterinary Medical Forum of the American College of Veterinary Internal Medicine, San Diego. p 723.
8. Bousquet-Melou, A., Bernard, S., Schneider, M. and Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine. vet. J. 34, 366-372.
9. Brown, S.A. (1996) Fluorquinolones in animal health. J. Vet. Pharmacol. Ther. 19, 1-14.
10. Carretero, M., Rodríguez, C., San Andrés, M.I., Forés, P., De Lucas, J.J., Nieto, J., Wasxman, S., San Andrés, M.D. and Gonzalez, F. (2002) Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine. vet. J. 24, 360-365.
11. Cester, C., Schneider, M. and Toutain, P.L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Rev. med. Vet. 147, 703-716.
12. Drlica, K. and Zhao, X. (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377-392.
13. Drusano, G.L., Johnson, D.E., Rosen, M. and Standiford, H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob. Agents Chemother. 37, 483-490.
14. Fernández-Varón, E., Bovaira, M.J., Espuny, A., Escudero, E., Vancraeynest, D. and Cárceles, C.M. (2005) Pharmacokinetic- pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. J. vet. Pharmacol. Therap. 27, 57-60.
15. Gardner, S.Y., Davis, J.L., Jones, S.L., Lafevers, D.H., Hoskins, M.S., McArver, E.M. and Papich, M.G. (2004) Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. J. vet. Pharmacol. Ther. 27, 57-60.
16. Gibaldi, M. and Perrier, D. (1982) In: Pharmacokinetics, 2nd edn., Marcel & Dekker, New York. pp 445-449.
17. Giguère, S., Sweeney, R.W. and Bèlanger, M. (1996) Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids and endometrial tissues after repeated intragastrically administered doses. Am. J. vet. Res. 57, 1025-1030.
18. Kaartinen, L., Panu, S. and Pyorala, S. (1997) Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine. vet. J. 29, 378-381.
19. Langston, VC., Sedrish, S. and Boothe, D.M. (1996) Disposition of single-dose oral enrofloxacin in the horse. J. vet. Pharmacol. Ther. 19, 316-319.
20. Lauritzen, B., Lykkesfeldt, J. and Friis, C. (2003) Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs. Res. vet. Sci. 74, 271-277.
21. Lode, H., Borner, K. and Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clin. Infect. Dis. 27, 33-39.
22. McKellar, Q., Gibson, I., Monteiro, A. and Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subutaneous administration. Antimicrob. Agents Chemother. 43, 1988-1992.
23. Papich, MG. (2001) Current concepts in antimicrobial therapy. In: Proceedings of the 18th Annual Veterinary Medical Forum of the American College of Veterinary Internal Medicine, Eds: D.J. Davenport and M.R. Paradis, ACVIM. pp 513-516.
24. Papich, M.G., Van Camp, S.D., Cole, J.A. and Whitacre, M.D. (2002) Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. J. vet. Pharmacol. Ther. 25, 343-350.
25. Park, S.C., Yun, H.I., Choi, Y.Y. and Oh, T.K. (1994) Pharmacokinetics of norfoxacin in horses and rabbits after intravenous, intramuscular or oral administration. In: Proceedings of the 6th International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT), Blackwell Scientific Publications, London. pp 46-47.
26. Shem-Tov, M., Rav-Hon, O., Ziv, G., Lavi, E., Glickman, A. and Saran, A. (1998) Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. J. vet. Pharmacol. Therap. 21, 209-213.
27. Shumaker, R.C. (1986) PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug. Metab. Rev. 17, 331-348.
28. Siefert, H.M., Domdey-Bette, A., Henninger, F., Hucke, F., Kohlsdorfer, C. and Stass, H.H. (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J. Antimicrob. Chemother. 43, Suppl. B, 69-76.
29. Spreng, M., Deleforge, J., Thomas, E., Boisrame, B. and Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J. vet. Pharmacol. Ther. 18, 284-289.
30. TerHune, T.N., Skogerboe, T.L., Shostrom, V. and Weigel, D.J. (2005) Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica. Am. J. vet. Res. 66, 342-349.
31. Toutain, P.L. and Bousquet-Melou, A. (2004) Plasma clearance. J. vet. Pharmacol. Ther. 27, 415-425.
32. Toutain, P.L., Lassourd, V., Costes, G., Alvinerie, M., Bret, L., Lefebvre, H.P. and Braun, J.P. (1995) A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J. vet. Pharmacol. Ther. 18, 226-235.
33. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58, 29-36.
34. Wolfson, J.S. and Hooper, D.C. (1989) Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 2, 378-424.
35. Yamaoka, K., Nakagawa, T. and Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6, 165-175.
36. Yamaoka, K., Tamigawara, Y. and Uno, J. (1981) A pharmacokinetic analysis program (MULTI) for microcomputers. J. Pharmacobio. Dyn. 4, 879-885.